TITLE

Stability of compounded thioguanine oral suspensions

AUTHOR(S)
Aliabadi, Hamidreza Montazeri; Romanick, Marcel; Somayaji, Vishwa; Mahdipoor, Parvin; Lavasanifar, Afsaneh
PUB. DATE
May 2011
SOURCE
American Journal of Health-System Pharmacy;5/15/2011, Vol. 68 Issue 10, p900
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose. Updated information on the stability of compounded thioguanine oral suspensions prepared with currently available ingredients, as well as results of testing to determine if the addition of an antioxidant could extend shelf life by inhibiting formation of guanine, are presented. Methods. Using triturated thioguanine tablets, three compounded suspensions were prepared: (1) a reference formulation containing methylcellulose and simple syrup, (2) an equivalent formulation using Ora-Plus and Ora-Sweet, and (3) an antioxidant- containing formulation prepared by adding ascorbic acid to the equivalent formulation. The compounded batches were stored at room temperature (19-23 °C). The chemical stability of the suspensions was evaluated immediately after compounding and at weekly intervals by a validated liquid chromatography-mass spectrometry (LCMS) assay method; physical stability was evaluated by regular visual checks and weekly pH testing. Results. As demonstrated by serial LCMS testing, mean thioguanine levels in sampled batches of all three suspensions remained above accepted standards and mean guanine formation remained within acceptable limits for up to 63 days. The addition of ascorbic acid appeared to slow guanine formation but did not significantly extend the shelf life of the suspension. Conclusion. Compounded oral suspensions of thioguanine 20 mg/mL exhibited acceptable chemical and physical stability for up to nine weeks at 19-23 °C. The addition of ascorbic acid at a concentration of 0.1% to the suspension was not effective in consistently increasing the shelf life of the thioguanine suspensions.
ACCESSION #
61138855

 

Related Articles

  • Stability of extemporaneously prepared glycopyrrolate oral suspensions. Cober, Mary Petrea; Johnson, Cary E.; Sudekum, David; Penprase, Kimberly // American Journal of Health-System Pharmacy;5/1/2011, Vol. 68 Issue 9, p843 

    Purpose. The stability of extemporaneously prepared glycopyrrolate 0.5-mg/mL suspensions was evaluated. Methods. An oral suspension of glycopyrrolate 0.5 mg/mL was prepared by thoroughly grinding 30 1-mg tablets of glycopyrrolate in a glass mortar. Thirty milliliters of Ora-Plus and 30 mL of...

  • Stability of extemporaneously prepared oxandrolone oral suspensions. Johnson, Cary E.; Cober, Mary Petrea; Hawkins, Katherine A.; Julian, Justin D. // American Journal of Health-System Pharmacy;3/15/2011, Vol. 68 Issue 6, p519 

    Purpose. The stability of extemporaneously prepared oxandrolone oral suspensions was studied. Methods. Oxandrolone oral suspension (1 mg/mL) was prepared using oxandrolone tablets, Ora-Plus, and either Ora-Sweet or Ora-Sweet SF. Three identical samples of each formulation were prepared and...

  • What can happen when suspensions are not shaken? Ellis, David P. // Journal of Pharmacy Practice & Research;Mar2011, Vol. 41 Issue 1, p79 

    A letter to the editor is presented which is concerned withe importance of shaking liquid medications.

  • A Simulation Study to Improve Performance in the Preparation and Delivery of Antineoplastic Medications at a Community Hospital. Lu, Tao; Wang, Shuli; Li, Jingshan; Lucas, Paul; Anderson, Mike; Ross, Kay // Journal of Medical Systems;Oct2012, Vol. 36 Issue 5, p3083 

    In this paper, we introduce a simulation study to improve the antineoplastic medication preparation and delivery performance at a pharmacy department in a large community hospital. The goal of this work is to help pharmacy reduce patients' average waiting time when receiving chemotherapy. This...

  • Evaluation of sources to document extended shelf lives of compounded cytostatics. Larsson, Iben; Kart, Trine // Journal of Oncology Pharmacy Practice;Dec2013, Vol. 19 Issue 4, p355 

    Background: Due to the increasing demand for compounded cytostatics, future compounding of these drugs has to include automated production and improved logistics, and in both cases batch production for stockholding is needed. This set-up would also meet future staff shortages. Stockholding...

  • A three-year study of a first-generation chemotherapy-compounding robot. NURGAT, ZUBEIR; FARIS, DIMA; MOMINAH, MAHER; VIBAR, ARRIS; AL-JAZAIRI, ABDULRAZAQ; EWING, SHEENA; ASHOUR, MOHAMMED; QAISI, SHROUQ KAMEL; BALHARETH, SAKRA; AL-JEDAI, AHMED // American Journal of Health-System Pharmacy;6/15/2015, Vol. 72 Issue 12, p1036 

    Purpose. Results of a performance evaluation of an automated system for compounding antineoplastic preparations are reported. Methods. Three years after the pharmacy department of a hospital in Saudi Arabia installed an i.v.-compounding robot (CytoCare, Health Robotics), data captured by the...

  • Comparison of 2 vitamin D supplementation modalities in newborns: adherence and preference. Rodd, Celia; Jean-Philippe, Sonia; Vanstone, Catherine; Weiler, Hope // Applied Physiology, Nutrition & Metabolism;Jun2011, Vol. 36 Issue 3, p414 

    Lack of adherence with vitamin D supplementation is still a risk factor for rickets. In a randomized cross-over design, infants received 400 IU cholecalciferol by dropper (1 mL syrup) or filmstrip. Infant and parent preference scores and adherence were then compared. Forty-three parents of...

  • Biological evaluation of transdichloridoplatinum( II) complexes with 3- and 4-acetylpyridine in comparison to cisplatin. Filipovic, Lana; Arandelovic, Sandra; Gligorijevic, Nevenka; Krivokuca, Ana; Jankovic, Radmila; Srdic-Rajic, Tatjana; Rakic, Gordana; Tesic, Zivoslav; Radulovic, Sinisa // Radiology & Oncology;2013, Vol. 47 Issue 4, p346 

    Background. In our previous study we reported the synthesis and cytotoxicity of two trans-platinum(II) complexes: trans-[PtCl2(3-acetylpyridine)2] ( 1) and trans-[PtCl2(4-acetylpyridine)2] ( 2), revealing significant cytotoxic potential of 2. In order to evaluate the mechanism underlying...

  • Stability of extemporaneously compounded diltiazem hydrochloride infusions stored in polyolefin bags. Kaushal, Gagan; Sayre, Brian E.; Prettyman, Terrence // American Journal of Health-System Pharmacy;5/15/2013, Vol. 70 Issue 10, p894 

    Purpose. The stability of extemporaneously compounded diltiazem hydrochloride infusions stored in polyolefin bags was studied. Methods. Sterile preparations of diltiazem hydrochloride were compounded to a concentration of 1 mg/mL in 5% dextrose solutions in accordance with United States...

  • Physical and chemical stability of high-dose ifosfamide and mesna for prolonged 14-day continuous infusion. Zhang, YanPing; Kawedia, Jitesh D; Myers, Alan L; McIntyre, Chelsey M; Anderson, Peter M; Kramer, Mark A; Culotta, Kirk S // Journal of Oncology Pharmacy Practice;Feb2014, Vol. 20 Issue 1, p51 

    Purpose: Ifosfamide plus mesna have been used recently in a high-dose regimen that allows this chemotherapy to be given to outpatients with less toxicity over 14 days using a portable pump. However, there is a need for published stability information. The aim of this study was to investigate the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics